403 results on '"Thompson, Gilbert A."'
Search Results
2. International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia
3. FH through the retrospectoscope
4. The future of clinical lipidology in the UK
5. Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989–2017
6. Use of apheresis in the age of new therapies for familial hypercholesterolaemia
7. Atherosclerosis in cholesterol-fed rabbits and in homozygous and heterozygous LDL receptor-deficient humans
8. HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom
9. Current Role of Lipoprotein Apheresis
10. Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes
11. In Memoriam: Nick Myant (1917–2015)
12. Managing homozygous familial hypercholesterolaemia from cradle to grave
13. Resolving the Cholesterol Controversy
14. The evidence-base for the efficacy of lipoprotein apheresis in combating cardiovascular disease
15. Lipoprotein Apheresis in the Management of Familial Hypercholesterolaemia: Historical Perspective and Recent Advances
16. Is Good Cholesterol Always Good? Genetic And Pharmacological Increases Of Hdl Cholesterol Need Further Evaluation
17. Efficacy criteria and cholesterol targets for LDL apheresis
18. Cholesterol Lowering Margarine Is Effective
19. Defects of Receptor-Mediated Low Density Lipoprotein Catabolism in Homozygous Familial Hypercholesterolemia and Hypothyroidism in vivo
20. Difference in Saturable Binding of Low Density Lipoprotein to Liver Membranes from Normocholesterolemic Subjects and Patients with Heterozygous Familial Hypercholesterolemia
21. AKIRA ENDO: THE DISCOVERY OF STATINS
22. An Indian Dance at Jemez, New Mexico
23. The scientific basis and future of lipoprotein apheresis
24. Use of Statins
25. Lipoprotein(a): the underestimated cardiovascular risk factor
26. Plasminogen activator inhibitor-1 removal using dextran sulphate columns. Evidence of PAI-1 homeostasis
27. Pioneers of Medicine Without a Nobel Prize
28. Measurement of the Reflectivity of the Intima-Medial Layer of the Common Carotid Artery Improves the Discriminatory Value of Intima-Medial Thickness Measurement as a Predictor of Risk of Atherosclerotic Disease
29. Management of hyperlipidemia in the pediatric population
30. Lipoprotein apheresis for the treatment of familial hypercholesterolemia
31. THE DISCOVERY OF THE LDL RECEPTOR AND ITS ROLE IN CHOLESTEROL METABOLISM
32. THE DISCOVERY OF THE STRUCTURE OF DNA
33. Nobel Prizes that Changed Medicine
34. Familial hypercholesterolaemia
35. Goals of statin therapy: Three viewpoints
36. PCSK9 Inhibitors for Homozygous Familial Hypercholesterolemia
37. Medicine My Vocation, Fishing My Recreation
38. Corrigendum to “Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989–2017” [Atherosclerosis 290 (November 2019) 44–51]
39. Lipoprotein apheresis
40. Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe
41. Which lipid fraction is the target and how often should this be monitored?
42. Dyslipidaemia in Clinical Practice, Second Edition
43. Comparison of Efficacy of Plant Stanol Ester and Sterol Ester: Short-Term and Longer-Term Studies
44. Additive Effects of Plant Sterol and Stanol Esters to Statin Therapy
45. History and Development of Plant Sterol and Stanol Esters for Cholesterol-Lowering Purposes
46. Combination therapy with statins
47. Current management of severe homozygous hypercholesterolaemias
48. Management of dyslipidaemia
49. Screening relatives of patients with premature coronary heart disease
50. LDL apheresis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.